Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
- Iddo Magen
- , Regina Ostritsky
- , Franziska Richter
- , Chunni Zhu
- , Sheila M. Fleming
- , Vincent Lemesre
- , Alistair J. Stewart
- , Bruce H. Morimoto
- , Illana Gozes*
- , Marie Françoise Chesselet
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
45
Scopus
citations